Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2023-04-11 Director's Dealing
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Thông báo giao dịch cổ phiếu của người nội bộ Trần Huy Chương
Director's Dealing Classification · 95% confidence The document is a Vietnamese filing notifying the State Securities Commission and the Ho Chi Minh Stock Exchange of an insider share transaction: a Board member (Trần Huy Chương) registering to sell 193,500 shares. This is a report of personal share transactions by a company director, matching the definition of Director’s Dealing (DIRS).
2023-04-11 Vietnamese
DBT: Báo cáo kết quả giao dịch cổ phiếu của NNB - Trần Huy Chương
Director's Dealing Classification · 89% confidence The document is a formal disclosure to the securities commission and stock exchange detailing share transactions by an insider (board member Trần Huy Chương) including number of shares sold, dates, and holdings before/after. This is a report of personal share transactions by a company director, fitting the “Director's Dealing” category.
2023-04-04 Vietnamese
DBT: Giải trình chênh lệch lợi nhuận sau thuế năm 2022 kiểm toán so với năm 2021
Report Publication Announcement Classification · 87% confidence The document is a brief regulatory disclosure (2,122 characters) announcing that the 2022 audited consolidated financial statements have been prepared and published on the company website. It does not contain the full report itself but simply states that the audited financials are available, meeting the criteria for a Report Publication Announcement rather than the actual Annual Report or Interim Report.
2023-04-04 Vietnamese
DBT: Thông báo ngày ĐKCC tham dự ĐHĐCĐ thường niên năm 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 75% confidence The document is a formal notice from the Ho Chi Minh City Stock Exchange announcing the record date (“ngày đăng ký cuối cùng”) and ex-rights date for shareholders to attend the Annual General Meeting for fiscal year 2022. It specifies the last registration date for exercising voting rights. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), since it is an official announcement related to shareholders’ voting rights.
2023-03-28 Vietnamese
DBT: Nghị quyết HĐQT về việc bán cổ phiếu CDP
Major Shareholding Notification Classification · 90% confidence The document is a public disclosure to the State Securities Commission and the Ho Chi Minh Stock Exchange by Bepharco (DBT) announcing the sale of 4,226,950 shares of CDP and that it will cease to be an affiliate. It is not a financial report, dividend notice, or board change but a notification of a material change in the company’s shareholding in another listed entity, crossing the affiliate threshold. This fits the "Major Shareholding Notification" category.
2023-03-22 Vietnamese
DBT: Nghị quyết HĐQT về việc điều chỉnh thời gian tổ chức ĐHĐCĐ thường niên năm 2023
Regulatory Filings Classification · 75% confidence The document is a formal notice filed with the securities regulator and stock exchange announcing a Board of Directors’ resolution to adjust the timing of the 2023 Annual General Meeting. It does not contain financial statements or earnings data (so not an IR/10-K/ER), nor is it a proxy solicitation package, dividend notice, or management change announcement. It is a general regulatory/compliance filing about meeting arrangements, which falls into the fallback “Regulatory Filings” category (RNS).
2023-03-22 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.